[{"id":"e84dfcb8-ed06-48f2-a68d-dc1bf332000f","acronym":"RICTOR_SC","url":"https://clinicaltrials.gov/study/NCT03166904","created_at":"2021-01-18T15:36:45.375Z","updated_at":"2024-07-02T16:36:59.456Z","phase":"Phase 2","brief_title":"Phase II Trial of AZD2014 in RICTOR Amplified Solid Cancer Patients Refractory to Standard Chemotherapy","source_id_and_acronym":"NCT03166904 - RICTOR_SC","lead_sponsor":"Samsung Medical Center","biomarkers":" RICTOR","pipe":" | ","alterations":" RICTOR amplification","tags":["RICTOR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e RICTOR amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e vistusertib (AZD2014)"],"overall_status":"Withdrawn","enrollment":"","initiation":"Initiation: 03/01/2018","start_date":" 03/01/2018","primary_txt":" Primary completion: 06/01/2018","primary_completion_date":" 06/01/2018","study_txt":" Completion: 07/31/2018","study_completion_date":" 07/31/2018","last_update_posted":"2019-05-20"}]